Cargando…
Effect of Choline Alphoscerate on the Survival of Glioblastoma Patients: A Retrospective, Single-Center Study
Cognitive impairment often occurs in glioblastoma (GBM) patients due to the tumor itself and treatment side effects. Choline alphoscerate (L-alpha-glycerylphosphorylcholine, GPC) is frequently used to compensate for cognitive impairment in GBM patients. This study was conducted to determine whether...
Autores principales: | Kim, Yeong Jin, Lee, Tae-Kyu, Noh, Myung-Giun, Jung, Tae-Young, Kim, In-Young, Jung, Shin, Lee, Kyung-Hwa, Moon, Kyung-Sub |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605462/ https://www.ncbi.nlm.nih.gov/pubmed/36294373 http://dx.doi.org/10.3390/jcm11206052 |
Ejemplares similares
-
Choline and Choline alphoscerate Do Not Modulate Inflammatory Processes in the Rat Brain
por: Tayebati, Seyed Khosrow, et al.
Publicado: (2017) -
Prognostic significance of E-cadherin and N-cadherin expression in Gliomas
por: Noh, Myung-Giun, et al.
Publicado: (2017) -
Primary glioblastoma in the pineal region: a case report and review of the literature
por: Moon, Kyung-Sub, et al.
Publicado: (2008) -
P300 latency changes in patients with mild cognitive impairment after taking choline alphoscerate; A preliminary study
por: Han, Su-Hyun, et al.
Publicado: (2018) -
Analysis of stromal PDGFR-β and α-SMA expression and their clinical relevance in brain metastases of breast cancer patients
por: Akanda, Md Rashedunnabi, et al.
Publicado: (2023)